Search results
Regional Business Director at Sanofi Genzyme · Accomplished Sales leader with extensive experience leading and developing sales professionals in the Pennsylvania, Maryland, Virginia and DC market...
- 500+
- 883
- Sanofi Genzyme
With Sanofi, we’re announcing that the U.S. FDA has accepted for review the sBLA for our investigational medicine for adults and adolescents with chronic spontaneous urticaria (CSU). CSU is a ...
View Anna Anderson's business profile as Regional Business Director, Respiratory at Sanofi. Find contact's direct phone number, email address, work history, and more.
Explore Sanofi's U.S. leadership in innovation and impact. Learn how our leaders drive forward-thinking strategies for a brighter future.
Jul 14, 2020 · Sanofi and MD Anderson scientists will collaborate on experimental design, applying a core set of biomarkers and assays. Joint projects also will apply novel investigational agents developed at Sanofi to existing tumor samples to obtain further data on their effects at different disease stages.
Jul 14, 2020 · The University of Texas MD Anderson Cancer Center and Sanofi today announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
Jun 10, 2024 · In 2023, Sanofi expanded its long-standing collaboration with the Anderson Lab, combining Sanofi's drug development capabilities and industry experience with the MIT researchers’ expertise in delivery technology for vaccines and messenger RNA therapies aimed at treating genetic diseases.
